| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |